Connect Biopharma Holdings Limited Weighted Average Fair Value At Measurement Date Share Options Granted
Connect Biopharma Holdings Limited (CNTB) had Weighted Average Fair Value At Measurement Date Share Options Granted of $10.6 as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Notes
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted · last filed 2022-03-31
- 2021-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $10.60.
- 2020-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $4.20.
- 2019-12-31: Weighted Average Fair Value At Measurement Date Share Options Granted $1.20.
| Period end | Weighted Average Fair Value At Measurement Date Share Options Granted |
|---|---|
| 2021-12-31 | $10.60 20-F · filed 2022-03-31 |
| 2020-12-31 | $4.20 20-F · filed 2022-03-31 |
| 2019-12-31 | $1.20 20-F · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |